82 related articles for article (PubMed ID: 11129284)
21. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.
Mahasreshti PJ; Navarro JG; Kataram M; Wang MH; Carey D; Siegal GP; Barnes MN; Nettelbeck DM; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2001 Jul; 7(7):2057-66. PubMed ID: 11448924
[TBL] [Abstract][Full Text] [Related]
22. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
[TBL] [Abstract][Full Text] [Related]
23. [Influence of p16 gene on the biological behavior of human hepatocellular carcinoma].
Huang JZ; Xia SS; Ye QF; Jiang HY
Ai Zheng; 2003 Jan; 22(1):46-9. PubMed ID: 12561435
[TBL] [Abstract][Full Text] [Related]
24. P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation.
Kobayashi S; Shirasawa H; Sashiyama H; Kawahira H; Kaneko K; Asano T; Ochiai T
Clin Cancer Res; 1999 Dec; 5(12):4182-5. PubMed ID: 10632358
[TBL] [Abstract][Full Text] [Related]
25. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.
Ghaneh P; Greenhalf W; Humphreys M; Wilson D; Zumstein L; Lemoine NR; Neoptolemos JP
Gene Ther; 2001 Feb; 8(3):199-208. PubMed ID: 11313791
[TBL] [Abstract][Full Text] [Related]
27. Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.
Kruklitis RJ; Singhal S; Delong P; Kapoor V; Sterman DH; Kaiser LR; Albelda SM
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):123-30. PubMed ID: 14752422
[TBL] [Abstract][Full Text] [Related]
28. Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer.
Kucharczuk JC; Elshami AA; Zhang HB; Smythe WR; Hwang HC; Tomlinson JS; Amin KM; Litzky LA; Albelda SM; Kaiser LR
Ann Thorac Surg; 1995 Sep; 60(3):593-7; discussion 597-8. PubMed ID: 7677485
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
30. [Gene therapy with tumor suppressor gene p53 and(or) p16 on the nude mice models of NSCLC in vivo].
Wu W; Zhang X; Qi X
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):403-5. PubMed ID: 11778504
[TBL] [Abstract][Full Text] [Related]
31. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
[TBL] [Abstract][Full Text] [Related]
32. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice.
Hosotani R; Miyamoto Y; Fujimoto K; Doi R; Otaka A; Fujii N; Imamura M
Clin Cancer Res; 2002 Apr; 8(4):1271-6. PubMed ID: 11948142
[TBL] [Abstract][Full Text] [Related]
33. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
34. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M
Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
[TBL] [Abstract][Full Text] [Related]
36. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis.
Hahn W; Ho SH; Jeong JG; Hahn EY; Kim S; Yu SS; Kim S; Kim JM
Gene Ther; 2004 May; 11(9):739-45. PubMed ID: 15103317
[TBL] [Abstract][Full Text] [Related]
37. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
38. Gene therapy with apoptin induces regression of xenografted human hepatomas.
van der Eb MM; Pietersen AM; Speetjens FM; Kuppen PJ; van de Velde CJ; Noteborn MH; Hoeben RC
Cancer Gene Ther; 2002 Jan; 9(1):53-61. PubMed ID: 11924525
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line.
Supriatno ; Harada K; Kawaguchi S; Onoue T; Yoshida H; Sato M
Oral Oncol; 2004 Aug; 40(7):679-87. PubMed ID: 15172637
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
